10 Best LanzaTech Alternatives & Competitors (2026)

Ginkgo Bioworks operates a large foundry that designs custom microbes for chemicals, materials, and ingredients. It offers end-to-end organism engineering and scale-up support rather than a pre-built acrylic acid package. Compared with Industrial Microbes, Ginkgo provides broader molecule flexibility but requires longer program timelines and higher upfront fees for custom strain development.

Genomatica develops fermentation processes that convert sugars into bio-based chemicals including 1,4-butanediol and acrylic acid precursors. It has reached commercial-scale partnerships and focuses on cost-competitive drop-in molecules. Versus Industrial Microbes, Genomatica emphasizes sugar feedstocks and has more published commercial volume data, while Industrial Microbes highlights ethanol and methane routes.

Amyris engineers yeast to produce sustainable ingredients and materials from plant sugars. Its platform has scaled multiple molecules for cosmetics and polymers. In comparison to Industrial Microbes, Amyris targets higher-value specialty markets and sells finished ingredients rather than licensing strains for bulk acrylic acid.

DuPont has long-standing bio-based materials programs and has explored fermentation routes to intermediates. It focuses on integrated materials solutions rather than standalone acrylic acid. Relative to Industrial Microbes, DuPont offers downstream polymer expertise but fewer public details on ethanol-to-acrylic acid strains.

Zymergen combined automation and machine learning to discover new bio-based materials and chemicals. It worked on performance polymers and films before its acquisition. Relative to Industrial Microbes, Zymergen emphasized novel molecules over direct petrochemical replacements like acrylic acid.

BASF develops and commercializes bio-based acrylic acid through internal R&D and partnerships. It has pilot-scale renewable acrylic acid and large existing petrochemical capacity. Compared with Industrial Microbes, BASF can supply both bio and conventional grades at global scale but has less emphasis on third-party strain licensing.

Cargill invests in bio-based intermediates and has partnered on fermentation routes to acrylic acid and other chemicals. It brings large-scale fermentation assets and agricultural feedstock access. Against Industrial Microbes, Cargill offers manufacturing muscle but typically works through joint ventures rather than pure strain licensing.

Novozymes supplies industrial enzymes and has supported bio-based chemical projects through strain improvement and process optimization. It does not produce acrylic acid itself. In contrast to Industrial Microbes, Novozymes sells enabling technology rather than complete acrylic acid bioprocess packages.

Gevo produces renewable alcohols and chemicals via engineered yeast fermentation of sugars. It targets aviation fuel and chemical markets. Versus Industrial Microbes, Gevo is further along in commercial ethanol and isobutanol production but has not announced acrylic acid as a primary product.